ustekinumab-srlf

ustekinumab-srlf (IMULDOSA) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.

IMULDOSA is a marketed brand name for ustekinumab-srlf. Check FDA Drugs@FDA for the current US label holder and prescribing information.

ustekinumab-srlf has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.